Alltracel Pharmaceuticals Plc., (“Alltracel”, or “the Company”), (AIM:AP.L), the Healthcare Innovation Group focused on the Wound Care, Oral Care, Cardiovascular Health and Cosmeceutical markets, is today pleased to announce it has begun a six month co-funded product development programme with a leading global commercialisation partner in the cosmeceuticals ingredient market. The successful conclusion of the programme will lead to both parties entering into an alliance to commercialise the PhytopeuticsTM range of dermal health solutions in the global cosmeceutical market.
